SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-009802
Filing Date
2019-08-01
Accepted
2019-08-01 17:21:07
Documents
50
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort6301910-qdoc.htm   iXBRL 10-Q 965264
2 EXHIBIT 31.1 cort63019ex311.htm EX-31.1 11476
3 EXHIBIT 31.2 cort63019ex312.htm EX-31.2 11460
4 EXHIBIT 32.1 cort63019ex321.htm EX-32.1 5776
5 EXHIBIT 32.2 cort63019ex322.htm EX-32.2 5642
  Complete submission text file 0001628280-19-009802.txt   4036821

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20190630.xsd EX-101.SCH 27098
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20190630_cal.xml EX-101.CAL 65298
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20190630_def.xml EX-101.DEF 86944
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20190630_lab.xml EX-101.LAB 373103
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20190630_pre.xml EX-101.PRE 203923
11 EXTRACTED XBRL INSTANCE DOCUMENT cort6301910-qdoc_htm.xml XML 639654
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 19993648
SIC: 2834 Pharmaceutical Preparations